High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.

BACKGROUND Vascular calcification is enhanced in chronic dialysis patients, possibly due to the insufficient removal of various intermediate molecular weight uraemic toxins such as interleukins with conventional membranes. In this study, we assessed the modulation of in vitro vascular calcification with the use of high cut-off (HCO) membranes in chronic dialysis patients. METHODS In a PERCI trial, 43 chronic dialysis patients were treated with conventional high-flux and HCO filters for 3 weeks in a randomized order following a 2-period crossover design. After each phase, serum predialysis samples were drawn. Calcifying human coronary vascular smooth muscle cells (VSMCs) were incubated with the patient's serum samples. Calcification was assessed with alkaline phosphatase (ALP) and alizarin red staining. In the clinical trial, HCO dialysis reduced the serum levels of the soluble tumour necrosis factor receptor (sTNFR) 1 and 2, vascular cell adhesion molecule 1 (VCAM-1) and soluble interleukin-2 receptor (sIL2R). We therefore investigated the in vitro effects of these mediators on vascular calcification. RESULTS VSMCs incubated with HCO dialysis serum showed a 26% reduction of ALP with HCO serum compared with high-flux serum. Alizarin was 43% lower after incubation with the HCO serum compared with the high-flux serum. While sIL2R and sTNFR 1 and 2 showed no effects on VSMC calcification, VCAM-1 caused a dose-dependent enhancement of calcification. CONCLUSIONS The use of HCO dialysis membranes in chronic dialysis patients reduces the procalcific effects of serum on VSMC in vitro. The mechanisms of the strong effect of HCO on in vitro calcification are not completely understood. One factor may be lower levels of VCAM-1 in HCO serum samples, since VCAM-1 was able to induce vascular calcification in our experiments. Neither sTNFR 1, sTNFR 2 nor sIL2R enhance vascular calcification in vitro. Regardless of the mechanisms, our results encourage further studies of highly permeable filters in chronic dialysis patients.

[1]  Chih-Yang Hsu,et al.  The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients , 2017, BioMed research international.

[2]  P. Cummins,et al.  Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. , 2016, Vascular pharmacology.

[3]  T. Arnett,et al.  Pyrophosphate: a key inhibitor of mineralisation. , 2016, Current opinion in pharmacology.

[4]  C. Stefanadis,et al.  Basic Mechanisms in Atherosclerosis: The Role of Calcium. , 2016, Medicinal chemistry (Shariqah (United Arab Emirates)).

[5]  P. Martus,et al.  High cut‐off dialysis in chronic haemodialysis patients , 2015, European journal of clinical investigation.

[6]  Daniel Q. Bach,et al.  Rapidly progressive nonuremic calciphylaxis in the setting of warfarin. , 2015, The American journal of medicine.

[7]  E. Salido,et al.  Artery Wall Assessment Helps Predict Kidney Transplant Outcome , 2015, PloS one.

[8]  W. C. O'Neill,et al.  Increased Vascular Calcification in Patients Receiving Warfarin , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[9]  T. Wolak.  Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease. , 2014, Atherosclerosis.

[10]  M. Feldmann,et al.  Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen‐Induced Arthritis , 2014, Arthritis & rheumatology.

[11]  M. Rosenfeld,et al.  Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6 , 2014, Journal of Vascular Research.

[12]  L. Tomlinson,et al.  Serum calcification propensity predicts all-cause mortality in predialysis CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[13]  I. Komuro,et al.  Association of serum IgG4 and soluble interleukin-2 receptor levels with epicardial adipose tissue and coronary artery calcification. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[14]  Xinying Li,et al.  Protective role of tumor necrosis factor (TNF) receptors in chronic intestinal inflammation: TNFR1 ablation boosts systemic inflammatory response , 2013, Laboratory Investigation.

[15]  Dhruv K. Singh,et al.  Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. , 2013, Clinical science.

[16]  M. Lindenmeyer,et al.  Distinct Contributions of TNF Receptor 1 and 2 to TNF-Induced Glomerular Inflammation in Mice , 2013, PloS one.

[17]  A. Boschetti-de-Fierro,et al.  Extended Characterization of a New Class of Membranes for Blood Purification: The High Cut-off Membranes , 2013, The International journal of artificial organs.

[18]  Z. Massy,et al.  Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Julius J Schmidt,et al.  New High-Cutoff Dialyzer Allows Improved Middle Molecule Clearance without an Increase in Albumin Loss: A Clinical Crossover Comparison in Extended Dialysis , 2012, Blood Purification.

[20]  S. Davidge,et al.  Estradiol Modulates Tumor Necrosis Factor-Induced Endothelial Inflammation: Role of Tumor Necrosis Factor Receptor 2 , 2012, Journal of Vascular Research.

[21]  N. Heyne,et al.  Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Rosenfeld,et al.  RANKL Enhances Macrophage Paracrine Pro-Calcific Activity in High Phosphate-Treated Smooth Muscle Cells: Dependence on IL-6 and TNF-α , 2012, Journal of Vascular Research.

[23]  K. Westlund,et al.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model. , 2012, Translational research : the journal of laboratory and clinical medicine.

[24]  Su‐Li Cheng,et al.  TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. , 2012, Endocrinology.

[25]  A. Caudrillier,et al.  Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification , 2011, Laboratory Investigation.

[26]  R. Bellomo,et al.  A Pilot, Randomized, Double-Blind, Cross-Over Study of High Cut-Off versus High-Flux Dialysis Membranes , 2009, Blood Purification.

[27]  Z. Al-Aly,et al.  Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. , 2008, Translational research : the journal of laboratory and clinical medicine.

[28]  Sharon M Moe,et al.  Mechanisms of vascular calcification in chronic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.

[29]  R. Bellomo,et al.  β2-Microglobulin Removal and Plasma Albumin Levels with High Cut-off Hemodialysis , 2007, The International journal of artificial organs.

[30]  C. Shanahan,et al.  VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: The Vascular Biology of Calcification , 2007 .

[31]  M. Rewers,et al.  Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. , 2006, The international journal of biochemistry & cell biology.

[32]  Z. Massy,et al.  Chronic kidney disease as cause of cardiovascular morbidity and mortality. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  P. Raggi,et al.  Determinants of progressive vascular calcification in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[35]  R. Bellomo,et al.  Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  C. Wanner,et al.  Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. , 2003, Kidney international. Supplement.

[38]  L. Demer,et al.  Matrix GLA Protein Modulates Differentiation Induced by Bone Morphogenetic Protein-2 in C3H10T1/2 Cells* , 2001, The Journal of Biological Chemistry.

[39]  F. Parhami,et al.  Tumor Necrosis Factor-&agr; Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway , 2000, Circulation.

[40]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[41]  R. Behringer,et al.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein , 1997, Nature.

[42]  H. Rabb,et al.  Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  M. Stoddart.  WST-8 analysis of cell viability during osteogenesis of human mesenchymal stem cells. , 2011, Methods in molecular biology.

[44]  K. Nitta,et al.  Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[45]  A. Covic,et al.  Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. , 1997, Nephron.